Congo vs Marshall Islands: Previously treated cases tested for RR-/MDR-TB
Congo
100.0%
in 2024
Marshall Islands
100.0%
in 2024
Congo rank
1st
Marshall Islands rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Congo
- Marshall Islands
How they compare
Congo currently reports 100.0% against 100.0% in Marshall Islands, a difference of 0.0%.
The two have swapped places 2 times across 11 shared years of data; in 2013 it was Marshall Islands ahead.
Congo ranks 1st and Marshall Islands ranks 1st of 180 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Marshall Islands in 1.
Head to head by decade
| Decade | Congo | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.2% | 59.8% | 17.3% | Congo |
| 2020s | 69.8% | 100.0% | 30.2% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Congo or Marshall Islands?
- Congo, at 100.0% against 100.0% in Marshall Islands as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Congo and Marshall Islands?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Marshall Islands?
- 11 years are reported by both, from 2013 to 2024.
- How do Congo and Marshall Islands rank globally for previously treated cases tested for rr-/mdr-tb?
- Congo ranks 1st and Marshall Islands ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.